Page last updated: 2024-08-23

raloxifene hydrochloride and midazolam

raloxifene hydrochloride has been researched along with midazolam in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (50.00)	29.6817
2010's	1 (50.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Baer, BR; Rock, DA; Wienkers, LC	1
Dalvie, D; Zientek, M	1

Other Studies

2 other study(ies) available for raloxifene hydrochloride and midazolam

Article	Year
Time-dependent inactivation of P450 3A4 by raloxifene: identification of Cys239 as the site of apoprotein alkylation. Chemical research in toxicology, 2007, Volume: 20, Issue:6 Topics: Alkylating Agents; Alkylation; Apoproteins; Binding Sites; Cysteine; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Endopeptidase K; Enzyme Inhibitors; Estrogen Antagonists; Glutathione; Iodoacetamide; Kinetics; Midazolam; Molecular Structure; Quinolines; Raloxifene Hydrochloride; Recombinant Proteins; Sequence Analysis, Protein; Spectrometry, Mass, Electrospray Ionization; Spectrophotometry, Ultraviolet; Time Factors	2007
Use of a multistaged time-dependent inhibition assay to assess the impact of intestinal metabolism on drug-drug interaction potential. Drug metabolism and disposition: the biological fate of chemicals, 2012, Volume: 40, Issue:3 Topics: Area Under Curve; Biotransformation; Cytochrome P-450 CYP3A; Drug Interactions; Humans; Intestinal Mucosa; Intestines; Kinetics; Liver; Midazolam; Raloxifene Hydrochloride	2012

Article

Year

Time-dependent inactivation of P450 3A4 by raloxifene: identification of Cys239 as the site of apoprotein alkylation.

Chemical research in toxicology, 2007, Volume: 20, Issue:6

Topics: Alkylating Agents; Alkylation; Apoproteins; Binding Sites; Cysteine; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Endopeptidase K; Enzyme Inhibitors; Estrogen Antagonists; Glutathione; Iodoacetamide; Kinetics; Midazolam; Molecular Structure; Quinolines; Raloxifene Hydrochloride; Recombinant Proteins; Sequence Analysis, Protein; Spectrometry, Mass, Electrospray Ionization; Spectrophotometry, Ultraviolet; Time Factors

2007

Use of a multistaged time-dependent inhibition assay to assess the impact of intestinal metabolism on drug-drug interaction potential.

Drug metabolism and disposition: the biological fate of chemicals, 2012, Volume: 40, Issue:3

Topics: Area Under Curve; Biotransformation; Cytochrome P-450 CYP3A; Drug Interactions; Humans; Intestinal Mucosa; Intestines; Kinetics; Liver; Midazolam; Raloxifene Hydrochloride

2012